Sorrento Therapeutics (SRNE)
OTHER OTC:SRNE
Holding SRNE?
Track your performance easily

Sorrento Therapeutics (SRNE) Balance Sheet

5,282 Followers

Sorrento Therapeutics Balance Sheet

Sorrento Therapeutics's total assets for Q2 2023 were $456.69M, a decrease of -0.73% from the previous quarter. SRNE total liabilities were $654.65M for the fiscal quarter, a 11.43% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 472.84M$ 694.82M$ 535.82M$ 557.63M$ 624.09M
Total Liabilities
$ 494.51M$ 616.69M$ 395.09M$ 524.88M$ 416.59M
Total Equity Gross Minority
$ -21.67M$ 78.13M$ 140.73M$ 32.76M$ 207.50M
Total Capitalization
$ 104.86M$ 189.38M$ 257.41M$ 277.68M$ 432.61M
Preferred Stock Equity
-----
Capital Lease Obligations
--$ 53.93M$ 55.43M$ 0.00
Currency in USD

Sorrento Therapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis